Skip to main content
ChemPartner PharmaTech Co., Ltd. logo

ChemPartner PharmaTech Co., Ltd. — Investor Relations & Filings

Ticker · 300149 ISIN · CNE100000Y27 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,256 across all filing types
Latest filing 2017-09-20 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300149

About ChemPartner PharmaTech Co., Ltd.

https://www.chempartner.com

ChemPartner PharmaTech Co., Ltd. is a global research and development organization providing comprehensive drug discovery and development services. Operating as a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), the company supports pharmaceutical and biotechnology clients through an integrated service platform. Core capabilities include medicinal chemistry, biology, pharmacology, drug metabolism and pharmacokinetics (DMPK), and toxicology. The organization also offers specialized expertise in biologics discovery, protein engineering, and antibody development. ChemPartner facilitates the transition from early-stage research to clinical development through its pharmaceutical development and manufacturing capabilities, utilizing advanced technology to accelerate the discovery and production of novel therapeutic agents.

Recent filings

Filing Released Lang Actions
关于量子磁系产业基金对外投资的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of an external investment by the Quantum Magnetic Industry Fund, a subsidiary or related entity of the company Quantum Hi-Tech (China) Biological Co., Ltd. It details the investment in a 10% equity stake in Shanghai Ruizhihua Chemical Research Co., Ltd., including transaction parties, asset details, financial indicators, agreement terms, and risk disclosures. The document is a formal disclosure of a capital investment transaction and related shareholder approvals, not a financial report, earnings release, or management discussion. It does not contain comprehensive financial statements or quarterly/yearly results but focuses on the capital investment and related transaction details. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length (5951 characters) and content support this classification with high confidence.
2017-09-20 Chinese
关于中止重大资产重组事项和产业基金购买上海睿智化学研究有限公司部分股权召开投资者说明会预告的公告
Investor Presentation Classification · 90% confidence The document is a short announcement (1256 characters) from a company about holding an investor conference call (investor explanation meeting) regarding the suspension of a major asset restructuring and a related equity purchase. It includes details about the meeting time, location (online platform), participants, and how investors can join and ask questions. There is no financial data, no full report, no voting results, no regulatory certification, and no detailed presentation attached. The document is essentially a notice about an upcoming investor meeting rather than the meeting materials or transcript itself. According to the rules, such announcements about meetings or presentations are best classified as Investor Presentation (IP) if they contain detailed presentation content, or Report Publication Announcement (RPA) if announcing report availability. However, this document is a meeting notice for an investor explanation session, which aligns best with Investor Presentation (IP) category as it is a detailed presentation for investors focusing on company matters and strategy, even though the actual presentation is to be held later. Therefore, the classification is IP with high confidence.
2017-09-20 Chinese
广发证券股份有限公司关于公司中止重大资产重组事项之独立财务顾问核查意见
Audit Report / Information Classification · 95% confidence The document is an independent financial advisor's verification opinion regarding the suspension of a major asset restructuring by a listed company. It discusses the timeline of the restructuring, stock suspension, board meetings, and the reasons for halting the restructuring. The document references regulatory rules related to major asset restructuring and includes an official opinion from the financial advisor. It does not contain financial statements or detailed financial results but is a formal verification and opinion report related to a corporate restructuring event. This fits the category of Audit Report / Information (AR), which includes standalone audit reports, applied accounting principles, and results of internal or regulatory checks related to corporate actions, excluding full annual reports or interim reports. The document length is 2259 characters, which is too long for a mere announcement but too short and focused for a full annual or interim report. Therefore, the best classification is AR with high confidence.
2017-09-20 Chinese
关于中止重大资产重组事项和产业基金购买上海睿智化学研究有限公司部分股权的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the suspension of a major asset restructuring transaction and related investment activities by Quantum Hi-Tech (China) Biological Co., Ltd. It includes information about the company's board meetings, decisions to suspend the transaction, regulatory inquiries, and the impact on the company. The text references the company's stock suspension and resumption, the involvement of a fund purchasing equity, and the strategic rationale behind the transaction. It is not a full financial report, earnings release, or audit report, but rather a regulatory announcement about a capital restructuring event and related corporate actions. The document is lengthy and detailed, not a brief notice or a simple report publication announcement. It fits best under the category of Capital/Financing Update (CAP), as it deals with updates on company fundraising, financing activities, and capital structure changes related to a major asset reorganization and equity investment.
2017-09-20 Chinese
独立董事关于第三届董事会第三十四次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding matters to be discussed at the 34th meeting of the third board of directors. It includes pre-approval opinions on the suspension of a share issuance and cash payment for asset acquisition and fundraising, a related party transaction involving a 10% equity transfer, and the cancellation of the use of surplus raised funds for a major asset restructuring. The document references regulatory rules and company bylaws, and it is signed by independent directors. The content is focused on board-level decisions and approvals rather than financial results, earnings, or audit findings. It is not a full annual or interim report, nor an earnings release or audit report. It is not a simple announcement but a detailed management/board opinion document related to corporate governance and board meeting matters. Therefore, the best fitting category is Board/Management Information (MANG). The document length is 2181 characters, which is relatively short but contains substantive board-related content, not just an announcement or certification.
2017-09-20 Chinese
第三届监事会第二十二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at the 22nd meeting of the third Supervisory Board of Quantum Hi-Tech (China) Biological Co., Ltd. It details decisions on suspending a major asset restructuring, approval of a related party transaction involving equity transfer, and cancellation of a previous funding use proposal. The document is a meeting resolution announcement by the Supervisory Board, not a full financial report, audit, or earnings release. It does not contain financial statements or detailed financial analysis but rather corporate governance decisions and approvals. The document length is short (2056 characters), and it is an official announcement of board resolutions. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement that does not fit other specific categories like MANG (which is for board or management changes) or CAP (capital updates).
2017-09-20 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.